Topical delivery of any drug is a challenge because largest organ in the human body, acts as a protective barrier. The delivery methods are of increasing interest, particularly the topical delivery of large molecules. Topical drugs, for example, sunscreens and astringents are utilized for prophylaxis. There are many ointments and creams that are applied to the skin are called as topical drugs. Different types of drops that are directly used are also called as topical drugs. Asthma patients who take the drugs for ease of respiratory are also termed as topical drugs. They are utilized as a part of the treatment of skin conditions, for example, bacterial, contagious, and viral diseases; irritation; pruritus; corns; warts; and other dermatologic conditions. Topical drug delivered includes the acquaintance of a medicine with the body surface, for example, skin or mucous film or to the circulatory system by intermittent transdermal medication delivered for the treatment of disease. It is considered as key course for nearby and systemic treatment. Drugs delivered through this course of administration enter profoundly into the skin and are better retained.
How Big is The Global Topical Drug Delivery Market?
The Global Topical Drug Delivery Market is expected to be around US$ 176.2 Billion by 2028 at a CAGR of 6% in the given forecast period.
The major driving factors of Global Infusion Topical Drug Delivery Market are as follows:
The restraining factors of Global Topical Drug Delivery Market are as follows:
The Global Topical Drug Delivery Market is segmented on the lines of its producttype, facility of use, route of administration and regional. Based on product type segmentation it covers formulation, devices.Based on facility of use segmentation it covers hospitals and private clinics, home care settings, others. Based on route of administration segmentation it covers skin, ophthalmic, rectal, vaginal and nasal. The Global Topical Drug Delivery Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Global Topical Drug Delivery Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Global Topical Drug Delivery Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets on Global Topical Drug Delivery Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include GlaxoSmithKline plc. (U.K.), Valeant Pharmaceuticals International, Inc. (Canada), Crescita Therapeutics Inc. (Canada), Medpharm (U.K.), Galderma S.A. (Switzerland), 3M (U.S.), Bayer AG (Germany), Novartis AG (Switzerland), Janssen Global Services, LLC (U.S.), and Cipla (India). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Topical Drug Delivery Market has been segmented as below:
By Product Type Analysis:
By Facility of Use Analysis:
By Route of Administration Analysis:
By Regional Analysis:
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Topical Drug Delivery Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Topical Drug Delivery Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Topical Drug Delivery Market, By Route of Administration
4.2 Topical Drug Delivery Market, By Product Type
4.3 Geographic Snapshot of the Topical Drug Delivery Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.3 Drivers
5.3.1 High Prevalence of Skin Diseases
5.3.2 Growing Preference for Topical Drug Delivery
5.3.3 High Incidence of Burn Injuries
5.3.4 Rising Incidence of Diabetes
5.3.5 Rising Geriatric Population
5.4 Restraints
5.4.1 Negative Impact of Product Recalls
5.5 Opportunities
5.5.1 Delivery of Biologics Through the Transdermal Route
5.5.2 Acquisition of Small Market Players
5.6 Challenges
5.6.1 Limited Therapeutic Areas of Topical Drug Delivery
6 Topical Drug Delivery Market, By Product Type
6.1 Introduction
6.1.1 Formulations
6.1.1.1 Liquid Topical Formulations
6.1.1.1.1 Solutions
6.1.1.1.2 Suspensions
6.1.1.2 Semi-Solid Topical Formulations
6.1.1.2.1 Creams
6.1.1.2.2 Gels
6.1.1.2.3 Ointments
6.1.1.2.4 Pastes
6.1.1.2.5 Lotions
6.1.1.3 Solid Topical Formulations
6.1.1.3.1 Suppositories
6.1.1.3.2 Powders
6.1.2 Devices (Transdermal Drug Delivery)
6.1.2.1 Transdermal Patches
6.1.2.2 Transdermal Gels
7 Topical Drug Delivery Market, By Route of Administration
7.1 Introduction
7.2 Skin Drug Delivery
7.3 Ophthalmic Drug Delivery
7.4 Rectal Drug Delivery
7.5 Vaginal Drug Delivery
7.6 Nasal Drug Delivery
8 Topical Drug Delivery Market, By Facility of Use
8.1 Introduction
8.2 Hospitals and Private Clinics
8.3 Home Care Settings
8.4 Other Facilities of Use
9 Topical Drug Delivery Market, By Region
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Rest of Europe (RoE)
9.4 Asia-Pacific (APAC)
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest of APAC
9.5 Rest of the World
10 Competitive Landscape
10.1 Overview
10.2 Player Ranking
10.3 Competitive Situation and Trends
10.3.1 Product Launches and Approvals
10.3.2 Acquisitions
10.3.3 Agreements & Collaborations
10.3.4 Expansions
11 Company Profiles
11.1 Glaxosmithkline PLC
11.2 Janssen Global Services, LLC. (A Subsidiary of Johnson & Johnson)
11.3 Novartis AG
11.4 Galderma S.A.
11.5 Valeant Pharmaceuticals International, Inc.
11.6 Bayer AG
11.7 3M Drug Delivery Systems
11.8 Crescita Therapeutics Inc.
11.9 Medpharm
11.10 Cipla
The Global Topical Drug Delivery Market has been segmented as below:
By Product Type Analysis:
By Facility of Use Analysis:
By Route of Administration Analysis:
By Regional Analysis:
SUBSCRIBE TO OUR NEWSLETTERS
